SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2018-04-17
Tx date 2018-04-12 		$LILY
Callitas Health Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
+60,000 vol 		64,000
Filed 2018-04-17
Tx date 2018-04-12 		$LILY
Callitas Health Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
Warrants at an exercise price of $0.32; Expiry: April 15, 2020
16 - Acquisition or disposition under a prospectus exemption
+60,000 vol 		60,000
Filed 2018-04-17
Tx date 2015-05-14 		$LILY
Callitas Health Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
Warrants at an exercise price of $0.32; Expiry: April 15, 2020
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2018-04-12 		$LILY
Callitas Health Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
Convertible Debentures 10% per annum; due April 15, 2020
16 - Acquisition or disposition under a prospectus exemption
+$15,000 vol 		$15,000
Filed 2018-04-17
Tx date 2015-05-14 		$LILY
Callitas Health Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
Convertible Debentures 10% per annum; due April 15, 2020
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2018-04-12 		$LILY
Callitas Health Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
+12,000 vol 		76,000
Filed 2017-10-20
Tx date 2017-09-12 		$MQ
Callitas Health Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation 		$-57,600
-720,000 vol
$0.08 each 		900,000
Filed 2017-10-20
Tx date 2017-09-12 		$MQ
Callitas Health Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-36,000 vol 		4,000
Filed 2017-10-20
Tx date 2017-09-12 		$MQ
Callitas Health Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation 		$-30,600
-180,000 vol
$0.17 each 		1,620,000
Filed 2017-10-20
Tx date 2017-09-12 		$MQ
Callitas Health Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation 		$-57,600
-720,000 vol
$0.08 each 		180,000
Filed 2017-10-20
Tx date 2017-10-17 		$MQ
Callitas Health Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+100,000 vol 		280,000
Filed 2017-10-20
Tx date 2017-09-12 		$MQ
Callitas Health Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
Warrants at an exercise price of $0.08; Expiry: September 7, 2018
37 - Stock split or consolidation 		$-2,880
-36,000 vol
$0.08 each 		4,000
Filed 2017-10-20
Tx date 2016-09-07 		$MQ
M Pharmaceutical Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
10% Convertible Debentures due September 7, 2019
16 - Acquisition or disposition under a prospectus exemption
+$10,000 vol
Filed 2017-10-20
Tx date 2016-09-07 		$MQ
M Pharmaceutical Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
10% Convertible Debentures due September 7, 2019
16 - Acquisition or disposition under a prospectus exemption
+$10,000 vol 		$10,000
Filed 2017-01-30
Tx date 2017-01-26 		$MQ
M Pharmaceutical Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+800,000 vol 		1,800,000
Filed 2016-09-11
Tx date 2015-05-14 		$MQ
M Pharmaceutical Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
10% Convertible Debentures due September 7, 2019
00 - Opening Balance-Initial SEDI Report
Filed 2016-09-11
Tx date 2015-05-14 		$MQ
M Pharmaceutical Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
Warrants at an exercise price of $0.08; Expiry: September 7, 2018
00 - Opening Balance-Initial SEDI Report
Filed 2016-09-11
Tx date 2016-09-07 		$MQ
M Pharmaceutical Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
Warrants at an exercise price of $0.08; Expiry: September 7, 2018
16 - Acquisition or disposition under a prospectus exemption
+40,000 vol 		40,000
Filed 2016-09-11
Tx date 2015-05-14 		$MQ
M Pharmaceutical Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-09-11
Tx date 2016-09-07 		$MQ
M Pharmaceutical Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
+40,000 vol 		40,000
Filed 2016-09-11
Tx date 2016-09-07 		$MQ
M Pharmaceutical Inc. 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
10% Convertible Debentures due September 7, 2019
16 - Acquisition or disposition under a prospectus exemption
+$10,000 vol 		$10,000
Filed 2016-07-26
Tx date 2016-07-25 		$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+800,000 vol 		1,000,000
Filed 2015-06-19
Tx date 2015-05-14 		$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-06-19
Tx date 2015-06-15 		$MQ
M Pharmaceutical Inc. (formerly First Sahara Energy Inc.) 		Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+200,000 vol 		200,000